Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James L Riley

Showing results (11-20 of 127) with videos related to

Pageof 13
Sort By:
Plos Pathogens|October 3, 2012
The battle over mTOR: an emerging theatre in host-pathogen immunitySunil Martin, Bhaskar Saha, James L Riley
Seminars in Immunopathology|January 2, 2025
Cell therapies for viral diseases: a new frontierDavid Nardo, Emileigh G Maddox, James L Riley
Frontiers in Immunology|October 16, 2019
CAR Talk: How Cancer-Specific CAR T Cells Can Instruct How to Build CAR T Cells to Cure HIVGloria B Kim, Kristen Hege, James L Riley
Trends in Immunology|March 6, 2007
Signalling to suit function: tailoring phosphoinositide 3-kinase during T-cell activationRichard V Parry, James L Riley, Stephen G Ward
Nature Reviews. Immunology|July 27, 2018
CAR T cells for infection, autoimmunity and allotransplantationColby R Maldini, Gavin I Ellis, James L Riley
Immunity|May 26, 2009
Human T regulatory cell therapy: take a billion or so and call me in the morningJames L Riley, Carl H June, Bruce R Blazar
Nature Reviews. Genetics|February 19, 2021
Genetic engineering of T cells for immunotherapyGavin I Ellis, Neil C Sheppard, James L Riley
Nature Reviews. Immunology|October 28, 2009
Engineering lymphocyte subsets: tools, trials and tribulationsCarl H June, Bruce R Blazar, James L Riley
Molecular Cell|August 12, 2008
The paracaspase MALT1 controls caspase-8 activation during lymphocyte proliferationHolli Kawadler, Mary A Gantz, James L Riley, et al.
The Journal of Infectious Diseases|February 15, 2021
Challenges and Opportunities of Using Adoptive T-Cell Therapy as Part of an HIV Cure StrategyYuqi Zhou, Colby R Maldini, Julie Jadlowsky, et al.
Pageof 13

Showing results (11-20 of 127) with videos related to

Sort By:
Pageof 13
Plos Pathogens|October 3, 2012
The battle over mTOR: an emerging theatre in host-pathogen immunitySunil Martin, Bhaskar Saha, James L Riley
Seminars in Immunopathology|January 2, 2025
Cell therapies for viral diseases: a new frontierDavid Nardo, Emileigh G Maddox, James L Riley
Frontiers in Immunology|October 16, 2019
CAR Talk: How Cancer-Specific CAR T Cells Can Instruct How to Build CAR T Cells to Cure HIVGloria B Kim, Kristen Hege, James L Riley
Trends in Immunology|March 6, 2007
Signalling to suit function: tailoring phosphoinositide 3-kinase during T-cell activationRichard V Parry, James L Riley, Stephen G Ward
Nature Reviews. Immunology|July 27, 2018
CAR T cells for infection, autoimmunity and allotransplantationColby R Maldini, Gavin I Ellis, James L Riley
Immunity|May 26, 2009
Human T regulatory cell therapy: take a billion or so and call me in the morningJames L Riley, Carl H June, Bruce R Blazar
Nature Reviews. Genetics|February 19, 2021
Genetic engineering of T cells for immunotherapyGavin I Ellis, Neil C Sheppard, James L Riley
Nature Reviews. Immunology|October 28, 2009
Engineering lymphocyte subsets: tools, trials and tribulationsCarl H June, Bruce R Blazar, James L Riley
Molecular Cell|August 12, 2008
The paracaspase MALT1 controls caspase-8 activation during lymphocyte proliferationHolli Kawadler, Mary A Gantz, James L Riley, et al.
The Journal of Infectious Diseases|February 15, 2021
Challenges and Opportunities of Using Adoptive T-Cell Therapy as Part of an HIV Cure StrategyYuqi Zhou, Colby R Maldini, Julie Jadlowsky, et al.
Pageof 13